About Ubrogepant free base trihydrate 109.8 mg equivalent to Ubrogepant 100 mg
Class: | CGRP receptor antagonist
Use: | Acute treatment of migraine in adults
Adult dose: | 50 mg to 100 mg taken orally as needed; may repeat after 2 hours if needed, not to exceed 200 mg in a 24-hour period
Pediatric dose: | Safety and efficacy not established in patients under 18 years of age
Side effects: | Nausea, somnolence, dry mouth, fatigue
Contraindications: | Hypersensitivity to ubrogepant or any component of the formulation
Storage: | Store at room temperature, 20°C to 2
Drug Class
CGRP receptor antagonist
Uses & Indications
Acute treatment of migraine in adults
Storage Requirements
Store at room temperature, 20°C to 25°C (68°F to 77°F); protect from moisture
Manufacturer & Packaging
Manufacturer: Allergan Sales LLC [New Jersey;United States of America], United States of America
Package Size
10's (1's Unit-Dose Packet x 10)
Price & Supplier
Price in UAE: AED 1734.00
Dosage Information
Adult Dose
50 mg to 100 mg taken orally as needed; may repeat after 2 hours if needed, not to exceed 200 mg in a 24-hour period
Pediatric Dose
Safety and efficacy not established in patients under 18 years of age
Side Effects
Nausea, somnolence, dry mouth, fatigue
Contraindications & Precautions
Hypersensitivity to ubrogepant or any component of the formulation
Important Warnings
Risk of hypersensitivity reactions; not for the prevention of migraine; use caution in patients with severe renal impairment
Related Medicines in Same Category
See also: Other CGRP receptor antagonist medicines available in UAE pharmacies
Atogepant
Rimegepant
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.